S.Amdt. 4017Senate115th Congress (2017-2019)2nd degree
S.Amdt. 4017
Sponsored by
Sen. Edward J. Markey (D-MA)
Submitted September 17, 2018
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
September 17, 2018
Text
Submitted
SA 4017. Mr. MARKEY (for himself and Mr. Hatch) submitted an amendment intended to be proposed to amendment SA 4013 proposed by Mr. Alexander to the bill H.R. 6, to provide for opioid use disorder prevention, recovery, and treatment, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place, insert the following: SEC. __. LABELING OF PRESCRIPTION OPIOIDS. (a) In General.--Section 305(c) of the Controlled Substances Act (21 U.S.C. 825(c)) is amended-- (1) by inserting ``(1)'' before ``The Secretary''; and (2) by adding at the end the following: ``(2) The label of any container or package containing an opioid or opiate listed in schedule II or III shall, when dispensed (other than administered) to or for a patient, contain a clear, concise warning, in a manner specified by the Secretary by regulation, that the opioids or opiates dispensed can cause dependence, addiction, and overdose.''. (b) Regulations.-- (1) Regulations.--The Secretary of Health and Human Services shall prescribe regulations under section 503(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) to implement the amendment made by subsection (a) and such regulations shall be effective not later than 2 years after the date of enactment of this Act. (2) Interim rules.--The Secretary of Health and Human Services may issue the regulations required under paragraph (1) by interim rule to the extent necessary to comply with the timing requirement in paragraph (1). ______